Fortress Biotech, Inc.FBIONASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
+5.8%/yr
Long-term compound
Percentile
P74
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 13.45% |
| Q2 2025 | -10.21% |
| Q1 2025 | 23.47% |
| Q4 2024 | 13.49% |
| Q3 2024 | -12.77% |
| Q2 2024 | -11.52% |
| Q1 2024 | -1.72% |
| Q4 2023 | 11.28% |
| Q3 2023 | -16.69% |
| Q2 2023 | -31.43% |
| Q1 2023 | -10.45% |
| Q4 2022 | -9.04% |
| Q3 2022 | -11.10% |
| Q2 2022 | -10.78% |
| Q1 2022 | 2.88% |
| Q4 2021 | -2.78% |
| Q3 2021 | -2.47% |
| Q2 2021 | 6.93% |
| Q1 2021 | 17.28% |
| Q4 2020 | 12.69% |
| Q3 2020 | 10.17% |
| Q2 2020 | 17.40% |
| Q1 2020 | 1.03% |
| Q4 2019 | 2.18% |
| Q3 2019 | -2.50% |
| Q2 2019 | 13.33% |
| Q1 2019 | 42.23% |
| Q4 2018 | -37.31% |
| Q3 2018 | -5.04% |
| Q2 2018 | -10.64% |
| Q1 2018 | 7.78% |
| Q4 2017 | 0.35% |
| Q3 2017 | -1.90% |
| Q2 2017 | 17.90% |
| Q1 2017 | 24.12% |
| Q4 2016 | 17.40% |
| Q3 2016 | 48.29% |
| Q2 2016 | -6.53% |
| Q1 2016 | -11.55% |
| Q4 2015 | 36.55% |